Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 13, 2009 - Issue 1
Submit an article Journal homepage
127
Views
18
CrossRef citations to date
0
Altmetric
Review

Vitamin D and the vasculature: can we teach an old drug new tricks?

José M Valdivielso Hospital Universitario Arnau de Vilanova, Experimental Nephrology Laboratory & UDETMA Laboratorio de Investigación, Huav-Udl, Irblleida, Nephrology Service, Rovira Roure 80 25198, Lleida, Spain +34 973 003650; +34 973 702213; [email protected]
,
Blai Coll Hospital Universitario Arnau de Vilanova, Experimental Nephrology Laboratory & UDETMA Laboratorio de Investigación, Huav-Udl, Irblleida, Nephrology Service, Rovira Roure 80 25198, Lleida, Spain +34 973 003650; +34 973 702213; [email protected]
&
Elvira Fernandez Hospital Universitario Arnau de Vilanova, Experimental Nephrology Laboratory & UDETMA Laboratorio de Investigación, Huav-Udl, Irblleida, Nephrology Service, Rovira Roure 80 25198, Lleida, Spain +34 973 003650; +34 973 702213; [email protected]
Pages 29-38 | Published online: 19 Nov 2008

Bibliography

  • Holick MF, Frommer JE, Mcneill SC, et al. Photometabolism of 7-dehydrocholesterol to pre-vitamin-D3 in skin. Biochem Biophys Res Commun 1977;76:107-14
  • Okano T, Yasumura M, Mizuno K, et al. Photochemical conversion of 7-dehydrocholesterol into vitamin-D3 in rat skins. J Nutr Sci Vitaminol (Tokyo) 1977;23:165-8
  • Hanewald KH, Rappoldt MP, Roborgh JR. Analysis of fat-soluble vitamins. 5. the antirachitic activity of previtamin-D3. Recueil des Travaux Chimiques des Pays-Bas. J R Neth Chem Soc 1961;80:1003-14
  • Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biologically active vitamin-D metabolite. Nature 1970;228:764-6
  • Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:S1080-6
  • Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81
  • Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005;97:13-9
  • Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nut 2006;84:18-28
  • Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol 2006;92:26-32
  • Ghazarian JG, Jefcoate CR, Knutson JC, et al. Mitochondrial cytochrome P450 - component of chick kidney 25-hydroxycholecalciferol-1α-hydroxylase. J Biol Chem 1974;249:3026-33
  • Merke J, Milde P, Lewicka S, et al. Identification and regulation of 1,25-dihydroxyvitamin-D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin-D3 – studies in cultured bovine aortic endothelial-cells and human dermal capillaries. J Clin Invest 1989;83:1903-15
  • Kawashima H. Receptor for 1,25-dihydroxyvitamin-D in a vascular smooth-muscle cell-line derived from rat aorta. Biochem Biophys Res Commun 1987;146:1-6
  • Somjen D, Weisman Y, Kohen F, et al. 25-hydroxyvitamin D-3-1 α-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005;111:1666-71
  • Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006;371:1-12
  • Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325-49
  • Kreitmair M, Mall T. Hypervitaminose durch grosse dosen vitamin D. München Med Vchnschr 1928;75:637
  • Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nut 2005;94:483-92
  • Krause R, Buhring M, Hopfenmuller W, et al. Ultraviolet B and blood pressure. Lancet 1998;352:709-10
  • Mortimer EA, Jr, Monson RR, Mac Mahon B. Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med 1977;296:581-5
  • Docio S, Riancho JA, Perez A, et al. Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies? J Bone Miner Res 1998;13:544-8
  • Zittermann A, Scheld K, Stehle P. Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women. Eur J Clin Nut 1998;52:501-6
  • Douglas AS, Allan TM, Rawles JM. Composition of seasonality of disease. Scott Med J 1991;36:76-82
  • Douglas AS, Dunnigan MG, Allan TM, et al. Seasonal variation in coronary heart disease in Scotland. J Epidemiol Community Health 1995;49:575-82
  • Enquselassie F, Dobson AJ, Alexander HM, et al. Seasons, temperature and coronary disease. Int J Epidemiol 1993;22:632-6
  • Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol 1981;10:337-41
  • Enterline PE, Rikli AE, Sauer HI, et al. Death rates for coronary heart disease in metropolitan and other areas. Public Health Rep 1960;75:759-66
  • Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nut 1995;61:S638-45
  • Mims FM, III. Significant reduction of UVB caused by smoke from biomass burning in Brazil. Photochem Photobiol 1996;64:814-6
  • Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-64
  • Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-53
  • Giovannucci E, Liu Y, Hollis BW, et al. 25-Hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008;168:1174-80
  • Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9
  • Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11
  • Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:1004-13
  • Marco MP, Craver L, Betriu A, et al. Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients. Am J Kidney Dis 2001;38:965-74
  • Teng M, Wolf M, Ofsthun MN, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005;16:1115-25
  • Teng M, Wolf M, Lowrie E, et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003;349:446-56
  • Tentori F, Hunt WC, Stidley CA, et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006;70:1858-65
  • Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-80
  • Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int 2006;70:351-7
  • Palmer SC, Mc Gregor DO, Macaskill P, et al. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007;147:840-53
  • Judd SE, Nanes MS, Ziegler TR, et al. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nut 2008;87:136-41
  • Kristal-Boneh E, Froom P, Harari G, et al. Association of calcitriol and blood pressure in normotensive men. Hypertension 1997;30:1289-94
  • Lind L, Hanni A, Lithell H, et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995;8:894-901
  • Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20:713-9
  • Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States – data from the third national health and nutrition examination survey. Arch Intern Med 2007;167:1159-65
  • Hintzpeter B, Mensink GBM, Thierfelder W, et al. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2007
  • Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-9
  • Wang L, Manson JE, Buring JE, et al. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 2008;51:1073-9
  • Forman JP, Bischoff-Ferrari HA, Willett WC, et al. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension 2005;46:676-82
  • Li YC, Kong J, Wei MJ, et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-38
  • Bian K, Ishibashi K, Bukoski RD. 1,25(OH)2D3 modulates intracellular Ca2+ and force generation in resistance arteries. Am J Physiol 1996;270:H230-7
  • Feres T, Vianna LM, Paiva AC, et al. Effect of treatment with vitamin D3 on the responses of the duodenum of spontaneously hypertensive rats to bradykinin and to potassium. Br J Pharmacol 1992;105:881-4
  • Borges AC, Feres T, Vianna LM, et al. Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol. Br J Pharmacol 1999;127:772-8
  • Borges AC, Feres T, Vianna LM, et al. Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 1999;34:897-901
  • Bukoski RD, Li JY, Bo J. Effect of long-term administration of 125 (OH)2 vitamin-D3 on blood-pressure and resistance artery contractility in the spontaneously hypertensive rat. Am J Hypertens 1993;6:944-50
  • Bukoski RD, Xue H. On the vascular inotropic action of 1,25-(OH)2 vitamin-D3. Am J Hypertens 1993;6:388-96
  • Haffner D, Hocher B, Muller D, et al. Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2;D-3. J Hypertens 2005;23:1067-75
  • Cardus A, Panizo S, Parisi E, et al. Differential effects of vitamin D analogues on vascular calcification. J Bone Miner Res 2007;22:860-6
  • Cardus A, Parisi E, Gallego C, et al. 1,25-dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 2006;69:1377-84
  • Koh E, Morimoto S, Fukuo K, et al. 1,25-dihydroxyvitamin-D3 binds specifically to rat vascular smooth-muscle cells and stimulates their proliferation in vitro Life Sci 1988;42:215-23
  • Tukaj C, Trzonkowski P, Kubasik-Juraniec J, et al. Quantifying division of aortal smooth muscle cells in culture stimulated by 1,25(OH)2D3. J Steroid Biochem Mol Biol 2007;103:525-8
  • Tukaj C. Enhanced proliferation of aortal smooth muscle cells treated by 1,25(OH)2D3 in vitro coincides with impaired formation of elastic fibres. Int J Exp Pathol 2008;89:117-24
  • Jono S, Nishizawa Y, Shioi A, et al. 1,25-dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 1998;98:1302-6
  • Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001;86:1633-7
  • Lind L, Pollare T, Hvarfner A, et al. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res 1989;11:141-7
  • Mak RH. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 1992;6:345-8
  • Jespersen B, Randlov A, Abrahamsen J, et al. Acute cardiovascular effect of 1,25-dihydroxycholecalciferol in essential hypertension. Am J Hypertens 1998;11:659-66
  • Shimamatsu K, Onoyama K, Fujimi S, et al. Does 1 alpha(OH)D3 treatment affect blood pressure levels in maintenance hemodialysis patients? Am J Nephrol 1988;8:471-5
  • Park CW, Oh YS, Shin YS, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999;33:73-81
  • Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986;105:649-54
  • Sugden JA, Davies JI, Witham MD, et al. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008;25:320-5
  • Talmor Y, Golan E, Benchetrit S, et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 2008;294:F1059-64
  • Bernardi RJ, Johnson CS, Modzelewski RA, et al. Antiproliferative effects of 1α,25-dihydroxyvitamin D3 and vitamin D analogs on tumor-derived endothelial cells. Endocrinology 2002;143:2508-14
  • Chung I, Wong MK, Flynn G, et al. Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells. Cancer Res 2006;66:8565-73
  • Chung I, Yu WD, Karpf AR, et al. Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. J Steroid Biochem Mol Biol 2007;103:768-70
  • Mitsuhashi T, Morris RC, Ives HE. 1,25-Dihydroxyvitamin-D3 modulates growth of vascular smooth-muscle cells. J Clin Invest 1991;87:1889-95
  • Maccarthy EP, Yamashita W, Hsu A, et al. 1,25-Dihydroxyvitamin-D3 and rat vascular smooth-muscle cell-growth. Hypertension 1989;13:954-9
  • Wu-Wong JR, Nakane M, Ma J, et al. Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 2006;186:20-8
  • Mohtai M, Yamamoto T. Smooth muscle cell proliferation in the rat coronary artery induced by vitamin D. Atherosclerosis 1987;63:193-202
  • Razzaque MS, Sitara D, Taguchi T, et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 2006;20:720-2
  • Hass GM, Trueheart RE, Taylor CB, et al. An experimental histologic study of hypervitaminosis D. Am J Pathol 1958;34:395-431
  • Kent SP, Vawter GF, Dowben RM, et al. Hypervitaminosis D in monkeys; a clinical and pathologic study. Am J Pathol 1958;34:37-59
  • Atkinson J, Poitevin P, Chillon JM, et al. Vascular Ca overload produced by vitamin D3 plus nicotine diminishes arterial distensibility in rats. Am J Physiol 1994;266:H540-7
  • Bas A, Lopez I, Perez J, et al. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 2006;21:484-90
  • Shroff R, Egerton M, Bridel M, et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008;19:1239-46
  • Doherty TM, Tang W, Dascalos S, et al. Ethnic origin and serum levels of 1α,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 1997;96:1477-81
  • Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997;96:1755-60
  • Arad Y, Spadaro LA, Roth M, et al. Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis 1998;9:513-8
  • London GM, Guerin AP, Verbeke FH, et al. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007;18:613-20
  • Zemplenyi T, Mrhova O. Vascular enzyme activity changes accompanying the induction of experimental atherosclerosis. 2. Rats fed excess vitamin D. J Atheroscler Res 1965;5:548-55
  • Taura S, Taura M, Kamio A, et al. Vitamin D-induced coronary atherosclerosis in normolipemic swine: comparison with human disease. Tohoku J Exp Med 1979;129:9-16
  • Kunitomo M, Kinoshita K, Bando Y. Experimental atherosclerosis in rats fed a vitamin D, cholesterol-rich diet. J Pharmacobiodyn 1981;4:718-23
  • Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47:C7-12
  • Lin R, Amizuka N, Sasaki T, et al. 1α,25-dihydroxyvitamin D3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. J Bone Miner Res 2002;17:1604-12
  • Cardus A, Panizo S, Encinas M, et al. 1,25-Dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 2008; published online 29 August 2008, doi:10.1016/j.atherosclerosis.2008.08.020
  • Rebsamen MC, Sun JX, Norman AW, et al. 1α,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 2002;91:17-24
  • Giulietti A, Van Etten E, Overbergh L, et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D3 works as anti-inflammatory. Diabetes Res Clin Pract 2007;77:47-57
  • Staeva-Vieira TP, Freedman LP. 1,25-dihydroxyvitamin D3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 2002;168:1181-9
  • Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002;195:603-16
  • Panichi V, De Pietro S, Andreini B, et al. Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Kidney Int 1998;54:1463-9
  • Aihara K, Azuma H, Akaike M et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004;279:35798-802
  • Wu-Wong JR, Nakane M, Ma J. Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells. J Vasc Res 2007;44:11-8
  • Gossl M, Versari D, Mannheim D, et al. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia – implications for vulnerable plaque-development. Atherosclerosis 2007;192:246-52
  • Shah F, Balan P, Weinberg M, et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med 2007;12:291-7
  • Nakagawa K, Sasaki Y, Kato S, et al. 22-Oxa-1α,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 2005;26:1044-54
  • Bao BY, Yao J, Lee YF. 1α, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 2006;27:1883-93
  • Albert DM, Scheef EA, Wang S, et al. Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci 2007;48:2327-34

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.